Skip to main content


Single-Use Digital Flexible Ureteroscope

Transitional Pass-Through (TPT) Payment

Effective January 1, 2023, U.S. Centers for Medicare & Medicaid Services (CMS) has created a new Transitional Pass-Through (TPT) payment category which describes single-use endoscopes, including the LithoVue Single-Use Digital Flexible Ureteroscope, under the Medicare hospital outpatient prospective payment system (OPPS).55 Hospital Outpatient Departments and Ambulatory Surgery Centers may obtain additional, separate Medicare reimbursement for devices with TPT status, in addition to reimbursement for the procedure(s) furnished during the patient encounter.56 The intent of TPT payment is to facilitate Medicare beneficiary access to the advantages of innovative devices by allowing for adequate payment.57

A new device billing code will be effective January 1, 2023.




Endoscope, single-use (i.e., disposable), urinary tract, imaging/illumination device (insertable)⁵⁸

Boston Scientific recommends the new C-Code be considered for use in charging and billing for single-use ureteroscopes, including the LithoVue Single-Use Digital Flexible Ureteroscope.⁵⁹ Payments will vary by facility based on hospital reported charges.
If you have additional questions, please reach out to your local sales representative, or contact us.
Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules, and policies. This information is presented for illustrative purposes only and does not constitute reimbursement, coverage, coding, or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services, and to submit appropriate codes, charges, and modifiers for services rendered. It is also always the provider’s responsibility to understand and comply with Medicare national coverage determinations (NCD), Medicare local coverage determinations (LCD), and any other coverage requirements established by relevant payers which can be updated frequently. Boston Scientific recommends that you consult with your payers, reimbursement specialists, and/or legal counsel regarding coding, coverage, and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label. Information included herein is current as of November 2022 but is subject to change without notice. Rates for services are effective January 1, 2023. TPT code and payment is effective January 1, 2023.
Decorative blue line.

The Evidence: Single-Use vs. Multi-Use Flexible Ureteroscopes

A growing body of evidence supports the financial, operational and clinical benefits the LithoVue™ System offers your facility, healthcare professionals and patients.

Have you ever considered what happens to your reusable ureteroscope after you complete a procedure?

Decorative blue line.